336 related articles for article (PubMed ID: 28840395)
1. Clopidogrel IBS Patients Have Higher Incidence of Gastrointestinal Symptoms Influenced by Age and Gender.
Soghomonyan S; Abdel-Rasoul M; Zuleta-Alarcon A; Grants I; Davila V; Yu J; Zhang C; Whitaker EE; Bergese SD; Stoicea N; Arsenescu R; Christofi FL
Dig Dis Sci; 2017 Oct; 62(10):2728-2743. PubMed ID: 28840395
[TBL] [Abstract][Full Text] [Related]
2. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal adverse events after dual antiplatelet therapy: clopidogrel is safer than ticagrelor, but prasugrel data are lacking or inconclusive.
Serebruany VL; Dinicolantonio JJ; Can MM; Pershukov IV; Kuliczkowski W
Cardiology; 2013; 126(1):35-40. PubMed ID: 23860246
[TBL] [Abstract][Full Text] [Related]
4. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
[TBL] [Abstract][Full Text] [Related]
5. A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry.
Mayer K; Schulz S; Bernlochner I; Morath T; Braun S; Hausleiter J; Massberg S; Schunkert H; Laugwitz KL; Kastrati A; Sibbing D
Thromb Haemost; 2014 Aug; 112(2):342-51. PubMed ID: 24718389
[TBL] [Abstract][Full Text] [Related]
6. Symptoms and dietary practices of irritable bowel syndrome patients compared to controls: results of a USA national survey.
Pauls RN; Max JB
Minerva Gastroenterol Dietol; 2019 Mar; 65(1):1-10. PubMed ID: 30293415
[TBL] [Abstract][Full Text] [Related]
7. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
[TBL] [Abstract][Full Text] [Related]
8. Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial.
Reed GW; Cannon CP; Waalen J; Teirstein PS; Tanguay JF; Berger PB; Angiolillo DJ; Price MJ
Catheter Cardiovasc Interv; 2017 Feb; 89(2):190-198. PubMed ID: 26909669
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in dietary coping with gastrointestinal symptoms.
Faresjö A; Johansson S; Faresjö T; Roos S; Hallert C
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):327-33. PubMed ID: 19550348
[TBL] [Abstract][Full Text] [Related]
10. Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.
Lee CG; Lee JK; Kang YS; Shin S; Kim JH; Lim YJ; Koh MS; Lee JH; Kang HW
Am J Gastroenterol; 2015 Feb; 110(2):310-9. PubMed ID: 25583325
[TBL] [Abstract][Full Text] [Related]
11. The STIB score: a simple clinical test to predict clopidogrel resistance.
Legrand D; Barbato E; Chenu P; Magne J; Vrolix M; Wijns W; Legrand V;
Acta Cardiol; 2015 Oct; 70(5):516-21. PubMed ID: 26567810
[TBL] [Abstract][Full Text] [Related]
12. Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Aradi D; Komócsi A; Vorobcsuk A; Serebruany VL
Thromb Haemost; 2013 Jan; 109(1):93-101. PubMed ID: 23197191
[TBL] [Abstract][Full Text] [Related]
13. The effect of acenocoumarol on the antiplatelet effect of clopidogrel.
Dewilde WJ; Janssen PW; Bergmeijer TO; Kelder JC; Hackeng CM; ten Berg JM
Thromb Haemost; 2015 Oct; 114(4):708-16. PubMed ID: 26177793
[TBL] [Abstract][Full Text] [Related]
14. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).
Kirtane AJ; Parikh PB; Stuckey TD; Xu K; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Parvataneni R; Maehara A; Généreux P; Mehran R; Stone GW
JACC Cardiovasc Interv; 2015 Dec; 8(15):1978-1987. PubMed ID: 26738669
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome.
Ringel Y; Williams RE; Kalilani L; Cook SF
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):68-72; quiz 3. PubMed ID: 19124113
[TBL] [Abstract][Full Text] [Related]
17. Clinical determinants of clopidogrel responsiveness in a heterogeneous cohort of Puerto Rican Hispanics.
Hernandez-Suarez DF; Scott SA; Tomey MI; Melin K; Lopez-Candales A; Buckley CE; Duconge J
Ther Adv Cardiovasc Dis; 2017 Sep; 11(9):235-241. PubMed ID: 28675986
[TBL] [Abstract][Full Text] [Related]
18. Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA.
Tuteja AK; Talley NJ; Gelman SS; Alder SC; Thompson C; Tolman K; Hale DC
Dig Dis Sci; 2008 Jan; 53(1):271-6. PubMed ID: 17549631
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.
Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
Aliment Pharmacol Ther; 2014 Feb; 39(3):312-21. PubMed ID: 24308816
[TBL] [Abstract][Full Text] [Related]
20. Irritable bowel syndrome: a population based study.
Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
